This study has focused on identifying the role of K103.3 on SCLC cell death by activated Jurkat T cells; however, we cannot exclude the possibility that CD8-positive cytotoxic T cells participate in T cell-mediated cell death of SCLCs in vivo. This evidence concerns the gene CD8A and small cell lung carcinoma.